Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnVision Instruments is a molecular diagnostics company that develops portable, low-cost testing platforms for infectious diseases. The company's proprietary EnVision (Enzyme-assisted Nanoscale Visual Nucleic Acid Testing) platform integrates CRISPR-Cas technology with cell-free systems to detect specific genetic sequences with high sensitivity. This technology is designed to operate outside of traditional laboratory settings, providing visual results without the need for complex instrumentation or stable electricity. EnVision's primary focus is on addressing global health challenges by providing rapid diagnostic tools for pathogens such as Zika, Ebola, and SARS-CoV-2.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnVision Instruments.